Beijing Chunlizhengda Medical Instruments Co., Ltd. (HKG:1858)
Hong Kong
· Delayed Price · Currency is HKD 12.26
+0.05 (0.41%)
Apr 29, 2026, 4:08 PM HKT
HKG:1858 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 7,558 | 8,722 | 4,729 | 9,542 | 9,282 | 11,148 | Upgrade
|
| Market Cap Growth | 38.02% | 84.43% | -50.44% | 2.80% | -16.74% | 47.19% | Upgrade
|
| Enterprise Value | 5,092 | 6,544 | 2,606 | 7,832 | 7,563 | 10,429 | Upgrade
|
| Last Close Price | 12.26 | 14.86 | 8.38 | 11.52 | 14.44 | 13.48 | Upgrade
|
| PE Ratio | 15.52 | 28.76 | 35.56 | 31.18 | 26.68 | 28.17 | Upgrade
|
| Forward PE | 12.02 | 19.82 | 10.02 | 12.89 | 14.67 | 11.29 | Upgrade
|
| PS Ratio | 6.49 | 7.50 | 5.52 | 7.17 | 6.83 | 8.20 | Upgrade
|
| PB Ratio | 2.27 | 2.62 | 1.58 | 3.01 | 3.02 | 3.68 | Upgrade
|
| P/TBV Ratio | 2.37 | 2.74 | 1.65 | 3.18 | 3.18 | 3.89 | Upgrade
|
| P/FCF Ratio | 19.65 | 22.67 | - | 18.10 | 509.88 | - | Upgrade
|
| P/OCF Ratio | 16.78 | 19.36 | - | 16.93 | 200.22 | 55.12 | Upgrade
|
| PEG Ratio | - | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | Upgrade
|
| EV/Sales Ratio | 4.38 | 5.62 | 3.04 | 5.88 | 5.57 | 7.67 | Upgrade
|
| EV/EBITDA Ratio | 14.68 | 19.00 | 19.01 | 24.14 | 21.62 | 23.54 | Upgrade
|
| EV/EBIT Ratio | 16.93 | 21.76 | 26.63 | 27.21 | 23.78 | 24.67 | Upgrade
|
| EV/FCF Ratio | 13.24 | 17.01 | - | 14.86 | 415.45 | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0 | 0.00 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | Upgrade
|
| Debt / FCF Ratio | 0.01 | 0.01 | - | 0.00 | 0.08 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.74 | -0.74 | -0.67 | -0.73 | -0.63 | -0.70 | Upgrade
|
| Net Debt / EBITDA Ratio | -7.16 | -7.16 | -14.63 | -7.12 | -5.57 | -4.81 | Upgrade
|
| Net Debt / FCF Ratio | -6.41 | -6.41 | 36.90 | -4.38 | -107.04 | 50.12 | Upgrade
|
| Asset Turnover | 0.29 | 0.29 | 0.23 | 0.34 | 0.38 | 0.49 | Upgrade
|
| Inventory Turnover | 0.72 | 0.72 | 0.59 | 1.02 | 1.44 | 1.61 | Upgrade
|
| Quick Ratio | 4.26 | 4.26 | 4.17 | 3.78 | 4.21 | 5.16 | Upgrade
|
| Current Ratio | 5.21 | 5.21 | 5.20 | 4.44 | 4.66 | 5.57 | Upgrade
|
| Return on Equity (ROE) | 9.39% | 9.39% | 4.37% | 9.92% | 11.86% | 18.17% | Upgrade
|
| Return on Assets (ROA) | 4.74% | 4.74% | 1.62% | 4.63% | 5.49% | 9.48% | Upgrade
|
| Return on Invested Capital (ROIC) | 27.74% | 28.62% | 10.13% | 26.68% | 29.71% | 53.72% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.80% | 8.80% | 3.20% | 8.80% | 10.00% | 13.50% | Upgrade
|
| Earnings Yield | 4.01% | 3.48% | 2.81% | 3.21% | 3.75% | 3.55% | Upgrade
|
| FCF Yield | 5.09% | 4.41% | -1.15% | 5.52% | 0.20% | -0.38% | Upgrade
|
| Dividend Yield | 3.38% | 2.70% | 1.68% | 3.46% | 2.45% | 1.18% | Upgrade
|
| Payout Ratio | 6.87% | 6.87% | 136.44% | 43.21% | 16.23% | - | Upgrade
|
| Buyback Yield / Dilution | -1.35% | -1.35% | 1.84% | -0.32% | -10.97% | -0.30% | Upgrade
|
| Total Shareholder Return | 1.96% | 1.35% | 3.52% | 3.14% | -8.52% | 0.88% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.